Expand BBIO Menu
BBIO MENU

BBIO Stock Posts


Upcoming Earnings

BBIO Bridgebio Pharma67.39-0.52 (-0.8%)

Bridgebio Pharma will report earnings after the market closes. View Calendar The market is expecting a ±12.6% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±4.9%. View Expected Move (Conf Call: Feb 24 4:30 PM)
Unusual Option Volume

BBIO Bridgebio Pharma68.89-1.83 (-2.6%)

Bridgebio Pharma trades 4,066 contracts. BBIO will report earnings on Feb 24, 2026.
Unusual Option Volume

BBIO Bridgebio Pharma79.18+5.85 (+8.0%)

Bridgebio Pharma trades 5,421 contracts. The company has the following event: BridgeBio Investor Call and Webcast to Discuss Phase 3 PROPEL 3 Results for Oral Infigratinib in Achondroplasia on Feb 12, 2026. News: BridgeBio Reports Positive Phase 3 Topline Results for Oral Infigratinib with the First Statistically Significant Improvements in Body Proportionality in Achondroplasia
Unusual Option Volume

BBIO Bridgebio Pharma72.86+0.39 (+0.5%)

Bridgebio Pharma trades 5,661 contracts.
Unusual Option Volume

BBIO Bridgebio Pharma67.97+4.24 (+6.7%)

Bridgebio Pharma trades 5,489 contracts.
$BBIO Bearish pressure building up in the options market. On-Balance net option delta is -108 K.
Market Data Delayed 15 Minutes